The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy...
The post FDA permits marketing of AI-based device to detect diabetic retinopathy appeared first on European Pharmaceutical Review.
Original Article: FDA permits marketing of AI-based device to detect diabetic retinopathy